Edinburgh Orthopaedics, Royal Infirmary of Edinburgh, Edinburgh, UK.
Orthopaedics, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Bone Joint J. 2023 Sep 1;105-B(9):961-970. doi: 10.1302/0301-620X.105B9.BJJ-2023-0006.R3.
The primary aim was to assess whether robotic total knee arthroplasty (rTKA) had a greater early knee-specific outcome when compared to manual TKA (mTKA). Secondary aims were to assess whether rTKA was associated with improved expectation fulfilment, health-related quality of life (HRQoL), and patient satisfaction when compared to mTKA.
A randomized controlled trial was undertaken, and patients were randomized to either mTKA or rTKA. The primary objective was functional improvement at six months. Overall, 100 patients were randomized, 50 to each group, of whom 46 rTKA and 41 mTKA patients were available for review at six months following surgery. There were no differences between the two groups.
There was no difference between rTKA and mTKA groups at six months according to the Western Ontario and McMaster Universities osteoarthritis index (WOMAC) functional score (mean difference (MD) 3.8 (95% confidence interval (CI) -5.6 to 13.1); p = 0.425). There was a greater improvement in the WOMAC pain score at two months (MD 9.5 (95% CI 0.6 to 18.3); p = 0.037) in the rTKA group, although by six months no significant difference was observed (MD 6.7 (95% CI -3.6 to 17.1); p = 0.198). The rTKA group were more likely to achieve a minimal important change in their WOMAC pain score when compared to the mTKA group at two months (n = 36 (78.3%) vs n = 24 (58.5%); p = 0.047) and at six months (n = 40 (87.0%) vs n = 29 (68.3%); p = 0.036). There was no difference in satisfaction between the rTKA group (97.8%; n = 45/46) and the mTKA group (87.8%; n = 36/41) at six months (p = 0.096). There were no differences in EuroQol five-dimension questionnaire (EQ-5D) utility gain (p ≥ 0.389) or fulfilment of patient expectation (p ≥ 0.054) between the groups.
There were no statistically significant or clinically meaningful differences in the change in WOMAC function between mTKA and rTKA at six months. rTKA was associated with a higher likelihood of achieving a clinically important change in knee pain at two and six months, but no differences in knee-specific function, patient satisfaction, health-related quality of life, or expectation fulfilment were observed.
本研究旨在评估与传统 TKA(mTKA)相比,机器人全膝关节置换术(rTKA)是否具有更好的早期膝关节特异性结果。次要目的是评估与 mTKA 相比,rTKA 是否与更高的期望满足度、更高的健康相关生活质量(HRQoL)和更高的患者满意度相关。
进行了一项随机对照试验,患者被随机分配至 mTKA 或 rTKA 组。主要观察指标为术后 6 个月的功能改善。共有 100 例患者接受了随机分组,每组 50 例,其中 rTKA 组和 mTKA 组分别有 46 例和 41 例患者在术后 6 个月接受了随访。两组患者在基线特征上没有差异。
在术后 6 个月时,rTKA 组和 mTKA 组在 Western Ontario and McMaster Universities 骨关节炎指数(WOMAC)功能评分上没有差异(平均差值(MD)为 3.8(95%置信区间(CI)-5.6 至 13.1);p = 0.425)。rTKA 组在术后 2 个月时 WOMAC 疼痛评分的改善更大(MD 9.5(95%CI 0.6 至 18.3);p = 0.037),但在术后 6 个月时没有观察到显著差异(MD 6.7(95%CI -3.6 至 17.1);p = 0.198)。与 mTKA 组相比,rTKA 组在术后 2 个月(n = 36(78.3%)比 n = 24(58.5%);p = 0.047)和 6 个月(n = 40(87.0%)比 n = 29(68.3%);p = 0.036)时 WOMAC 疼痛评分达到最小临床重要差异(MCID)的可能性更大。在术后 6 个月时,rTKA 组(97.8%;n = 45/46)与 mTKA 组(87.8%;n = 36/41)的患者满意度无差异(p = 0.096)。两组间的 EuroQol 五维问卷(EQ-5D)效用获益(p ≥ 0.389)或患者期望满足(p ≥ 0.054)没有差异。
在术后 6 个月时,mTKA 和 rTKA 在 WOMAC 功能方面的变化没有统计学上或临床上的显著差异。rTKA 与术后 2 个月和 6 个月时膝关节疼痛达到更明显的临床重要改善的可能性更高,但在膝关节特异性功能、患者满意度、健康相关生活质量或期望满足方面没有差异。